Crinetics Pharmaceuticals, Inc.
Driving the Next Generation of Endocrinology Care
San Diego, United States · Founded 2015 · $453.5M raised
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2015
- Business Model
- B2B
- Website
- crinetics.com
- Total Funding
- $453.5M
- Last Round
- $350.0M Venture RoundJan 2026
- Rounds
- 3
About
Crinetics Pharmaceuticals is a global biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics for endocrine diseases and endocrine-related tumors, including acromegaly and Cushing's disease. Its proprietary nonpeptide small-molecule platform has produced multiple clinical-stage candidates, including paltusotine (oral SST2 agonist) and atumelnant (oral ACTH antagonist). Founded in San Diego, the company is publicly traded on Nasdaq (CRNX) and has approximately 500–1,000 employees.
Summary
Crinetics Pharmaceuticals, Inc. is a Biotech company based in San Diego, United States, founded in 2015. It has raised $453.5M in total across 3 rounds, most recently a $350.0M Venture Round round in Jan 2026. Investors include 5AM Ventures, Rock Springs Capital and Adage Capital.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.